Copper Peptides for Skin: What GHK-Cu Does, What the Evidence Shows, and How to Layer It

Start with our pillar guide: Best Peptides for Skin: Peptide Ingredients in Skincare Ranked by Evidence, or browse all Peptide Science articles.

Copper peptides for skin have moved from serums to syringes. In September 2026, NPR reported that people are now injecting GHK-Cu under the skin, sometimes "stacked" with other peptides and often bought from grey-market online sellers, and that "there is no data from published human studies to show this practice is safe and effective" (NPR, Sept 7, 2026). Dermatologists quoted in the piece told patients to hold off.

The topical evidence is thinner than the hype suggests, too. NPR describes the human trials of copper-peptide creams as "generally small trials funded by the cosmetic industry." An independent 2025 review of the indexed literature went further and found "a surprising absence of clinical studies" on topical GHK-Cu (Mortazavi et al., 2025).

Short answer: Copper peptides for skin almost always means GHK-Cu (INCI name: copper tripeptide-1), a 3-amino-acid peptide bound to copper. In cell and animal studies it raises collagen and glycosaminoglycan production. Published human evidence is thin and mostly industry-run, and injecting it is untested. Evidence: lab/animal strong, human limited.

Key takeaways

• GHK-Cu boosted collagen synthesis in cultured fibroblasts at concentrations as low as 1 nanomolar (Maquart et al., 1988) and increased collagen in rat wounds (Maquart et al., 1993). Evidence: lab/animal only.
• Most of the facial "clinical trials" quoted online come from a single company's reviews and were never published in full in indexed journals. We explain which ones below.
• GHK-Cu is very water-loving (log D around −2.4), which makes it hard to push through the skin barrier (Badenhorst et al., 2016). Copper does reach the dermis in lab skin, but the intact peptide barely gets through without help (Li et al., 2015).
• Combining it with retinol is a matter of irritation, not a chemical conflict. Pairing it with low-pH L-ascorbic acid is a real formulation concern, so split them by time of day.
• If you want one proven anti-aging active, a retinoid has far more human data. Copper peptides are a supporting player.

This guide is the hub of our Peptide Science section. For the wider family (Matrixyl, Argireline, SNAP-8 and more), see our guide to peptide ingredients and how each class works. If your skin is irritated right now, start with how to repair your skin barrier before you add actives.

What is GHK-Cu (copper tripeptide-1)?

GHK-Cu is a 3-amino-acid peptide bound to copper, listed on labels as copper tripeptide-1. It occurs naturally in human plasma.

GHK stands for glycyl-L-histidyl-L-lysine, a tripeptide (a chain of 3 amino acids) that grabs copper(II) ions tightly. In cosmetics, the copper-bound form appears on labels as copper tripeptide-1. The EU CosIng database lists it as "a copper complex of Tripeptide-1" with the function skin conditioning (CosIng). That is a cosmetic category, not a drug claim. Don't confuse it with AHK-Cu, a lab-made cousin with alanine in place of glycine that's sold mostly in hair serums and has far less evidence; our AHK-Cu peptide guide covers what is and isn't known about it, and our review of copper peptides for hair covers the hair-growth evidence. For a side-by-side look at the two, see AHK-Cu vs GHK-Cu.

GHK occurs naturally in human plasma, saliva and urine. A review by Loren Pickart, who first isolated it, reports plasma levels of about 200 ng/mL at age 20 that fall to about 80 ng/mL by age 60 (Pickart et al., 2015). That decline is often used to market GHK-Cu as "replacing what you lost." But a drop in plasma levels does not show that a cream changes anything in your skin. Those are two separate questions.

The GHK sequence also sits inside the α2 chain of type I collagen. One proposal is that it is released when collagen breaks down at a wound and acts as a local "repair here" signal (Maquart et al., 1988). This is the logic behind calling it a signal and a carrier peptide: it signals fibroblasts and it carries copper.

There is one conflict of interest you should know about. Much of the GHK literature, including the two most cited reviews, comes from Pickart's company, Skin Biology (Pickart & Margolina, 2018; Pickart et al., 2015). The 2018 review declares no conflict of interest, but the author affiliations are commercial. We treat these reviews as useful maps of the literature, not as independent proof.

How do copper peptides work on skin?

In cell and animal studies, GHK-Cu increases collagen and glycosaminoglycan production and affects wound-healing pathways. Those mechanisms haven't been confirmed in controlled human facial trials.

Collagen and matrix synthesis (lab and animal)

The founding lab result: in fibroblast cultures, GHK-Cu stimulated collagen synthesis starting between 10⁻¹² and 10⁻¹¹ M, with a peak at 10⁻⁹ M (1 nanomolar), and the effect was not explained by more cells (Maquart et al., 1988). Semantic Scholar counts about 180 citations for this paper, so it is widely cited, but it is a cell study.

The animal follow-up implanted wound chambers in rats and injected GHK-Cu into them. Dry weight, DNA, total protein, collagen and glycosaminoglycans all rose in a dose-dependent way. Collagen rose twice as much as non-collagen protein, and type I and III collagen mRNA increased. A control tripeptide had no effect (Maquart et al., 1993). Evidence: lab/animal only. Injecting into a wound chamber is very different from applying a serum to intact facial skin.

A newer cell and ex-vivo study, run by two ingredient manufacturers, found GHK-Cu plus low-molecular-weight hyaluronic acid raised collagen IV 25.4-fold in fibroblasts and 2.03-fold in ex-vivo skin at a 1:9 ratio (Jiang et al., 2023). Evidence: lab only; manufacturer-funded.

Enzyme and remodeling effects (lab)

GHK-Cu is not a one-way collagen switch. Pickart's review describes it as stimulating both the synthesis and the breakdown of collagen and glycosaminoglycans, and as adjusting both matrix metalloproteinases and their inhibitors (Pickart et al., 2015). In one liposome study, GHK-Cu inhibited elastase by about 49% in a test-tube assay and had no meaningful effect on tyrosinase (Dymek et al., 2023). Evidence: lab only.

The "4,000 genes" claim (computational)

You will often read that GHK "resets" thousands of genes. The source is Pickart's analysis of the Broad Institute Connectivity Map, a database of gene-expression changes in cultured cancer cell lines exposed to compounds. The 2015 review says GHK can up- or downregulate "at least 4,000 human genes" (Pickart et al., 2015). This is a cell-line expression signature, not a measurement of human skin. We report it as a lab finding and drop the "resetting DNA to a healthier state" framing.

Do copper peptides for skin work in human studies?

The human evidence for copper peptides is where most copper-peptide articles overreach. Here is what we could and could not verify.

What a 2025 independent review concluded. A pharmaceutics team in Tehran reviewed topical GHK as an anti-wrinkle peptide. They concluded that cell studies clearly support it, but that for GHK-Cu and its palmitoylated cousin Pal-GHK "there is a surprising absence of clinical studies" (Mortazavi et al., 2025). They declared no conflict of interest. It's a single narrative review with about 12 citations so far (Semantic Scholar), so we treat its conclusion as limited evidence about the literature, not a final verdict.

The facial trials you see quoted everywhere. Pickart's 2015 review summarizes several placebo-controlled studies in women around age 50 (Pickart et al., 2015):

• A 12-week facial cream study in 71 women with mild to advanced photoaging, reporting improvements in laxity, clarity, fine lines, wrinkle depth and skin density.
• A 12-week eye-cream study in 41 women, compared against placebo and a vitamin K eye cream, reporting better results for GHK-Cu.
• A 12-week facial study in 67 women aged 50–59, reporting similar improvements.

The review cites these studies, but we could not find any of them as full peer-reviewed papers in PubMed or Europe PMC. They appear to be conference presentations. So we cannot check their randomization, blinding, effect sizes or funding. Evidence: limited and unverified. They point in a positive direction, but they are not the "clinically proven" result marketing makes them out to be.

The "70% vs vitamin C vs retinoic acid" study. The same review describes a study in which creams were applied to the thighs for 1 month. Collagen increased (judged by biopsy) in 70% of women using GHK-Cu, 50% using vitamin C and 40% using retinoic acid (Pickart et al., 2015, citing Abdulghani et al.). The original paper's own title calls it a pilot study, and it appeared in a journal not indexed in PubMed. Sample size is not reported in the review. Evidence: early / preliminary. It was thigh skin, not the face, and it was not a head-to-head trial powered to compare the three creams.

Microneedle combinations. Some trials use copper peptides alongside microneedling or in multi-ingredient patches. Their results cannot be credited to GHK-Cu alone, so we cover them in the aesthetic-treatments section rather than here.

Bottom line on efficacy: GHK-Cu has a strong, decades-old lab case and a weak, mostly unpublished human case. The honest label for "copper peptides reduce wrinkles" is Limited.

Do copper peptides actually absorb?

Whether copper peptides absorb is one of the most common questions in skincare communities: does a peptide as water-soluble as GHK-Cu get past the outer layer of skin (the stratum corneum) at all? The studies give a split answer.

The copper gets in. In human skin mounted in diffusion cells (in vitro), a 0.68% aqueous copper-tripeptide solution delivered copper through dermatomed skin. About 136 µg/cm² permeated over 48 hours, and about 82–97 µg/cm² stayed in the tissue as a reservoir (Hostynek et al., 2010; Hostynek et al., 2011). These studies measured copper, not the intact peptide, and they used "infinite dose" conditions, meaning far more product than you would apply.

The intact peptide mostly does not. A National University of Singapore team measured both peptide and copper. Through intact human skin, "almost no peptide or copper permeated" in 9 hours. After microneedle pretreatment, 134 nanomoles of peptide and 705 nanomoles of copper got through (Li et al., 2015). Evidence: lab only.

Why: GHK-Cu's distribution coefficient (log D) is about −2.4 across pH 4.5–7.4. That means it strongly prefers water over the oily lipids of the stratum corneum (Badenhorst et al., 2016). Formulators try liposomes, palmitoylation (attaching a fatty acid, as in Pal-GHK) and microneedles to get around this. A 2025 review notes that skin transport of liposomal GHK-Cu has "received little attention," so the claims for "encapsulated copper peptides" are untested (Ogórek et al., 2025).

What this means for you: Because GHK-Cu acts at nanomolar levels in cells, even a small amount that gets through could matter. But no study we found has measured how much intact GHK reaches the living dermis from a normal serum on normal facial skin. We don't know yet.

Can you use copper peptides with retinol, vitamin C or niacinamide?

The three questions below come up again and again in skincare forums. People are confused by brand instructions that say "don't use with other actives" while other users report mixing freely.

Copper peptides and retinol

No chemical conflict has been shown. We found no study showing that retinol or tretinoin inactivates GHK-Cu, or the reverse. The caution is about irritation load. Retinoids are the best-supported topical anti-aging ingredients you can buy. In a 24-week randomized, double-blind, vehicle-controlled trial in 36 elderly adults (mean age 87), 0.4% retinol applied to one arm reduced fine-wrinkle scores much more than vehicle (−1.64 vs −0.08 on a 9-point scale). It also increased glycosaminoglycans and procollagen I in biopsies (Kafi et al., 2007). Evidence: well-established for retinoids overall (Mukherjee et al., 2006; about 540 citations).

How to combine them: If your skin tolerates both, you can use them in the same evening routine. Apply the copper serum, let it dry, then apply the retinoid, or use them on alternating nights. If you are still building retinoid tolerance, keep copper peptides in the morning and the retinoid at night. No human study has tested whether the combination works better than either alone.

Copper peptides and vitamin C (the common conflict question)

This one has a real chemical basis, and that basis is mostly about what happens in the bottle and on the skin surface rather than in the dermis.

• L-ascorbic acid needs a low pH. In the key absorption study, L-ascorbic acid entered pig skin only when formulated below pH 3.5. Absorption peaked at 20%, and the common derivatives (magnesium ascorbyl phosphate, ascorbyl palmitate) did not raise skin vitamin C levels (Pinnell et al., 2001; about 216 citations).
• GHK-Cu is tested as stable between pH 4.5 and 7.4. It degraded under oxidative and basic stress and, "to a lesser extent," under acidic stress (Badenhorst et al., 2016). Nobody has published its stability at pH 3.
• Copper and ascorbate react. Copper(II) ions form a complex with the ascorbate anion as an intermediate in ascorbic acid oxidation (Hayakawa & Hayashi, 1977). This is 1977 test-tube chemistry in solution, not a skin study or a trial of any product. Evidence: lab only.

So a strongly acidic L-ascorbic acid serum layered right on top of a copper-peptide serum creates conditions where both ingredients could lose stability. No study has tested this on human skin, so we can't say how much efficacy you'd lose. The low-cost fix is to use vitamin C in the morning and copper peptides at night. If you use a neutral-pH vitamin C derivative, the concern is weaker, but derivatives also have less evidence for raising skin vitamin C (Pinnell et al., 2001). Topical vitamin C's own benefits beyond antioxidant protection are "poorly understood," according to a widely cited review (Pullar et al., 2017).

Copper peptides and niacinamide

The older internet rule ("niacinamide deactivates copper") has no study behind it that we could find. Niacinamide itself has decent human data from manufacturer-run trials. In a 12-week, double-blind, split-face trial of 50 women, 5% niacinamide reduced fine lines, hyperpigmented spots, red blotchiness and sallowness, and improved elasticity, compared with vehicle (Bissett et al., 2005; Procter & Gamble-funded). In other trials, 5% niacinamide reduced hyperpigmentation in 4 weeks (n=18 paired) and 2% niacinamide with sunscreen lightened tanned skin (n=120) (Hakozaki et al., 2002; P&G-funded). Evidence: moderate, largely from one manufacturer.

How to combine them: Same routine is fine. Introduce one product at a time so you can tell which one causes any reaction.

Copper peptides and exfoliating acids

Glycolic, lactic and salicylic acid products are formulated at low pH. Given GHK-Cu's tested stability window, keep acids and copper peptides at different times of day. This is a precaution based on formulation chemistry. No clinical trial has shown harm. If you use more than one acid, see layering salicylic and glycolic acid.

Copper peptides and hyaluronic acid

This is the one combination with a direct study behind it, but only in cells and ex-vivo skin, and funded by the manufacturers: GHK-Cu plus low-molecular-weight HA raised collagen IV more than either alone (Jiang et al., 2023). Evidence: lab only.

A sample layering plan

For a complete day-and-night routine built around these rules, see our step-by-step skincare protocol.

How do you choose and use copper peptides for skin?

Check the label for copper tripeptide-1, keep it apart from low-pH vitamin C, and introduce it on its own so you can spot irritation.

• Read the INCI list. Look for copper tripeptide-1. "Palmitoyl tripeptide-1" is Pal-GHK without copper, which is a different ingredient.
• Ignore percentage marketing. No published human dose-response study tells you that 1% beats 0.5%. Cells respond at nanomolar levels (Maquart et al., 1988), but how much reaches the dermis is unknown.
• Packaging. GHK-Cu is vulnerable to oxidative degradation (Badenhorst et al., 2016), so opaque, air-restricting packaging is sensible.
• Give it time. The unpublished facial studies used 12 weeks (Pickart et al., 2015). Expect nothing structural in the first month.
• Patch test. As with any new active, try it on a small area first and stop if you get redness that doesn't settle.

Who should be cautious with copper peptides?

People with metal allergies, at-home microneedlers and anyone pregnant or breastfeeding should check with a clinician first. Never inject cosmetic GHK-Cu.

• Copper or metal allergy: ask a dermatologist before using it.
• At-home microneedling: pretreatment sharply raised delivery of both peptide and copper (Li et al., 2015), which also raises exposure.
• Pregnant or breastfeeding: we found no pregnancy-specific safety data for topical GHK-Cu.

For reactions, irritation and injection risks in detail, see copper peptide side effects.

How do copper peptides compare with other anti-aging options?

Copper peptides have less human evidence than retinoids or daily sunscreen. The table below compares them by their strongest human data.

Matrixyl actually has a more verifiable published human trial than GHK-Cu, which may surprise anyone who reads only copper-peptide marketing. We compare the two head to head in Matrixyl vs copper peptides.

Where the evidence stops

• No independent, published, placebo-controlled facial RCT of a GHK-Cu serum that we could locate.
• No measurement of intact GHK reaching the living dermis from a normal serum on intact facial skin.
• No human study of GHK-Cu combined with retinoids, vitamin C or niacinamide.
• No dose-response data in humans.

Until those exist, treat copper peptides as a reasonable, low-irritation add-on, not a replacement for sunscreen and a retinoid.

FAQ

Can you use copper peptides and vitamin C together? Not in the same step if your vitamin C is L-ascorbic acid. It works below pH 3.5 (Pinnell et al., 2001), GHK-Cu has only been shown stable from pH 4.5 to 7.4 (Badenhorst et al., 2016), and copper reacts with ascorbate (Hayakawa & Hayashi, 1977). Use vitamin C in the morning and copper at night.

Can you use copper peptides with retinol or tretinoin? Yes. No study shows they inactivate each other. The issue is irritation. Alternate nights if your skin is reactive, or apply the copper serum first and let it dry before the retinoid.

Can you use copper peptides with niacinamide? Yes. We found no study supporting the old "they cancel out" rule. Add them one at a time so you can spot any reaction.

Do copper peptides actually absorb into the skin? Copper does reach deeper layers in lab skin (Hostynek et al., 2011), but almost no intact peptide passed through intact human skin in a 9-hour test (Li et al., 2015). How much works its way into the dermis from a real-world serum is unknown.

Are copper peptides as good as a retinoid? On current evidence, no. Retinoids have multiple controlled human trials (Mukherjee et al., 2006). Topical GHK-Cu has almost no published clinical trials (Mortazavi et al., 2025). Copper peptides can complement a retinoid but can't replace one.

How long do copper peptides take to work? The facial studies reported in the GHK literature ran for 12 weeks (Pickart et al., 2015). Give any peptide at least 8–12 weeks of consistent use before judging it.

Go deeper

• Peptide ingredients explained: signal, carrier, neurotransmitter and enzyme-inhibitor peptides
• Repairing your skin barrier: hydration and beyond
• A step-by-step skincare protocol for morning and evening
• Oral collagen supplements: what the trials show
• Matrixyl vs copper peptides: which has better evidence?
• Do peptides absorb into skin? What penetration studies show
• Peptides for menopause: what studies can and can't tell you

References

1. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. Bioimpacts. 2025. Narrative review. https://pubmed.ncbi.nlm.nih.gov/39963574/
2. Maquart FX, Pickart L, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu2+. FEBS Lett. 1988. In vitro. https://pubmed.ncbi.nlm.nih.gov/3169264/
3. Maquart FX, Bellon G, et al. In vivo stimulation of connective tissue accumulation by GHK-Cu2+ in rat experimental wounds. J Clin Invest. 1993. Animal (rat wound chamber). https://pubmed.ncbi.nlm.nih.gov/8227353/
4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015. Review (authors affiliated with Skin Biology). https://pubmed.ncbi.nlm.nih.gov/26236730/
5. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018. Review (authors affiliated with Skin Biology). https://pubmed.ncbi.nlm.nih.gov/29986520/
6. Jiang F, Wu Y, et al. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023. In vitro / ex vivo; manufacturer authors. https://pubmed.ncbi.nlm.nih.gov/37062921/
7. Dymek M, et al. Liposomes as carriers of GHK-Cu tripeptide for cosmetic application. Pharmaceutics. 2023. In vitro. https://pubmed.ncbi.nlm.nih.gov/37896245/
8. Hostynek JJ, Dreher F, Maibach HI. Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. Inflamm Res. 2010. In vitro (human skin). https://pubmed.ncbi.nlm.nih.gov/20703511/
9. Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011. In vitro (human skin). https://pubmed.ncbi.nlm.nih.gov/20721598/
10. Li H, et al. Microneedle-mediated delivery of copper peptide through skin. Pharm Res. 2015. In vitro + porcine. https://pubmed.ncbi.nlm.nih.gov/25690343/
11. Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native GHK tripeptide: a preformulation study for dermal delivery. Pharm Dev Technol. 2016. Lab. https://pubmed.ncbi.nlm.nih.gov/25384620/
12. Ogórek K, et al. Are we ready to measure skin permeation of modern antiaging GHK-Cu tripeptide encapsulated in liposomes? Molecules. 2025. Review. https://pubmed.ncbi.nlm.nih.gov/39795193/
13. Kafi R, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007. RCT, n=36, 24 weeks. https://pubmed.ncbi.nlm.nih.gov/17515510/
14. Mukherjee S, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006. Review. https://pubmed.ncbi.nlm.nih.gov/18046911/
15. Pinnell SR, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001. Animal (pig skin). https://pubmed.ncbi.nlm.nih.gov/11207686/
16. Hayakawa K, Hayashi Y. Detection of a complex intermediate in the oxidation of ascorbic acid by the copper(II) ion. J Nutr Sci Vitaminol. 1977. Solution chemistry. https://pubmed.ncbi.nlm.nih.gov/24090/
17. Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients. 2017. Review. https://pubmed.ncbi.nlm.nih.gov/28805671/
18. Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005. Split-face RCT, n=50, 12 weeks; P&G. https://pubmed.ncbi.nlm.nih.gov/16029679/
19. Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002. In vitro + clinical (n=18 paired; n=120); P&G. https://pubmed.ncbi.nlm.nih.gov/12100180/
20. Robinson LR, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005. Split-face RCT, n=93, 12 weeks; P&G. https://pubmed.ncbi.nlm.nih.gov/18492182/
21. Stone W. The copper peptide trend has gone from creams to injections — ahead of the science. NPR Morning Edition. September 7, 2026. News report. https://www.npr.org/2026/09/07/nx-s1-5955552/copper-peptides-skin-aging-health-safe
22. European Commission CosIng database: COPPER TRIPEPTIDE-1 (function: skin conditioning). https://ec.europa.eu/growth/tools-databases/cosing/

Disclosure: This article contains no affiliate links. It summarizes published research for general education and is not medical advice. Talk to a dermatologist or other clinician before starting prescription treatments or if you have a skin condition, allergy, or are pregnant.

For educational purposes only; not medical advice. See our disclaimer and research method.